TipRanks on MSN
Alnylam price target lowered to $351 from $370 at Leerink
Leerink analyst Mani Foroohar lowered the firm’s price target on Alnylam to $351 from $370 and keeps a Market Perform rating on the shares. Heading into 2026, the firm is refreshing its TTR market ...
Leerink raised the firm’s price target on Ionis Pharmaceuticals (IONS) to $100 from $85 and keeps an Outperform rating on the shares. Heading into ...
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback